SAN FRANCISCO, Jan. 30 (UPI) -- Swiss pharmaceutical giant Roche said it would initiate a tender offer to take over U.S. biotechnology company Genentech.
SOUTH SAN FRANCISCO, Calif., Aug. 14 (UPI) -- Swiss pharmaceutical behemoth Roche will have to dig deeper into its pockets if it wants to own all of Genentech Inc., which rejected its $43.7 billion offer.
BASEL, Switzerland, July 21 (UPI) -- Swiss drugmaker Roche Holding AG has offered $43.7 billion -- $89 a share -- for the U.S. biotech firm Genentech.
LOS ALTOS, Calif., Jan. 9 (UPI) -- U.S. firm Amphora Discovery Corporation said Tuesday Genentech agreed to purchase its oncology program for an undisclosed sum.
SOUTH SAN FRANCISCO, Calif., Nov. 10 (UPI) -- Genentech Inc. has agreed to buy Houston's Tanox Inc., maker of a successful asthma medicine, in an all-cash U.S. deal worth $919 million.
SOUTH SAN FRANCISCO, Calif., Nov. 10 (UPI) -- U.S. firm Genentech has announced it will acquire Tanox, its development partner on the asthma treatment Xolair.
SOUTH SAN FRANCISCO, Calif., June 30 (UPI) -- Genentech said Friday its drug Lucentis for wet age-related macular degeneration (AMD) has been OK'd for the U.S. market.
NEW YORK, Sept. 29 (UPI) -- Genentech, Inc., a biotech company in apparent danger of having a key U.S. patent withdrawn remains well-regarded by Wall Street.
SAN FRANCISCO, July 10 (UPI) --
LOS ANGELES, June 10 (UPI) --
